Internist Group Urges Routine HIV Testing MedPage Today, NJ - Early identification and treatment "provides a substantial health benefit" to the patient and modeling studies suggest early and successful therapy might ...
Patients thinking outside the Rx Albany Times Union, NY - ... the next generation of doctors and pharmacists to be open-minded. "Our students need to know about alternative and complementary therapy," Pohl said. ...
Doctors, researchers on quest for a cure News-Herald.com, OH - Nov 28, 2008 For years, the four stalwarts of cancer treatment have been early identification, radiation, chemical therapy and surgery. New science is making all of ...
Ultrasound, Shots Can Cure Heel Pain WDIV, MI - The release said that if those treatments don't work, people often try shockwave therapy, which is painful and takes multiple treatments. ...
Therapists on four legs find their calling Indianapolis Star, United States - Therapy dogs are house pets with a special affinity for people, a placid demeanor and solid, reliable obedience. Doctors, counselors, teachers, librarians, ...
Women make up 80% of health-care workforce: report CTV.ca, Canada - Women continue to dominate in nursing, physiotherapy and occupational therapy, and their ranks are increasing in male-dominated health-care professions. ...
Source: Google News
Recent News and Articles on the Keywords: 0.13 + 139 + therapy Related to the article below (Last Update: 8/7/2008)
Dsw Inc (DSW) newly added by Regions Financial Corp Mffais.com, CA - Jul 15, 2008 The stock is currently owned by 139 funds/institutions with a total activity score of 0.13. With 50.00 % of owning funds reported recently buying shares, ...RF
Markets trading weak; Realty Index slips 7% Moneycontrol.com, India - Jul 16, 2008 Top losers on the Sensex are DLF at Rs 390.50 down 8.54%, Jaiprakash Asso at Rs 139 down 4.37%, M&M at Rs 500.05 down 4.2%. Markets have completely given up ...
Marriott International Reports Second Quarter Results FOXBusiness - Jul 10, 2008 ... INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES AND MINORITY INTEREST 290 303 (4) Provision for income taxes (139) (128) (9) Minority interest, ...MAR
Transient visual disturbance after photodynamic therapy - S Mennel, CH Meyer - American Journal of Ophthalmology, 2005 - Elsevier ... retinal distance was reduced by 0.13 mm, corresponding to ... DJ, Fekrat S. Visual changes
after photodynamic therapy. ... Journal of Ophthalmology Volume 139, Issue 4 ...
Effectiveness of Leech Therapy in Osteoarthritis of the Knee: A Randomized, Controlled Trial - A Michalsen, S Klotz, R Ludtke, S Moebus, G Spahn, … - Annals of Internal Medicine, 2003 - annals.highwire.org ... 4 November 2003 | Volume 139 Issue 9 | Pages 724-730. ... life improved only for the
leech therapy group on ... were no longer detectable (difference, 0.13 [CI, ?0.31 ...
Measurement of Heparin in Patients Receiving Subcutaneous Heparin Therapy - KWE Denson, J Bonnar - British Journal of Haematology, 1975 - Blackwell Synergy Britishjournal offfuenratology, 1975, 30, 139. ... patictits during late prcgnancy who
wcre receiving heparin therapy. ...0.13 M sodium citratc containing 0.2 M HEPES ...
Source: Google Scholar
Why doctors are embracing Japanese therapy Johrei
Alternative treatments aren't always popular among medical circles.
But now several doctors are willing to carry out clinical trials on a Japanese well-being system called Johrei.
Doctors claim the self-healing technique could help to prevent minor ailments such as eczema and flu - which could mean fewer visits to GPs and, in turn, alleviate strain on local surgeries.
Some doctors are even hoping the technique might prolong the life of breast cancer victims.
Johrei is a technique based on the idea that the body can purify itself. And, say its followers, it offers an effective self-healing practice for both giver and receiver.
Practitioners believe that regular practice triggers a detoxification mechanism that helps strengthen the immune system and protect against infection.
And, doctors are so convinced by the claims, they are preparing to study the health benefits of Johrei.
The first study - due to start next month at the Imperial College of Medicine in London - will monitor women with breast cancer.
The study will observe three groups each receiving different treatments. One group will receive chemotherapy, the second self-hypnosis and the third group will learn and receive Johrei.
Although scientists are not expecting Johrei to reverse the affects of breast cancer, they are hoping that it will help strengthen the immune system and prevent the disease from developing into more advanced stages.
Michael Dixon, chairman of the NHS alliance, is also planning a one year research programme funded by the British Johrei Society. The clinical trials - which will take place at a NHS research unit next year - will monitor 30 young eczema sufferers and their families.
Each family member will be taught Johrei and will be expected to perform the technique on their relations each day. The idea is to monitor how each child's eczema will improve.
'This could prove to be an inexpensive safe treatment that reduces instances of minor ailments and hence fewer visits to the doctor,' says Dr Dixon, a GP who has employed a general healer in his surgery for ten years.
'The Johrei concept fits perfectly into new NHS plans which hope to improve patients' ability to treat themselves through alternative means.'
Research from America already shows that activity of killer cells - which attack bacteria and cancer cells - is increased if Johrei is practised several times a week.
Today, more than three million Japanese families practise Johrei. Although registered as a religion in Japan, it has been introduced in Britain as a practical lifestyle system based on clean living.
'Johrei has a place in our society for people who are not looking for a chemical quick fix,' says Dr Dixon. 'If our clinical trials prove to be successful, I hope that the NHS will view it as a useful way to build up healthier families and communities.'
However, the department of health are unable to say yet whether Johrei will be available on the NHS.
'We would need to look at the efficacy of the treatment and the outcome of the research before making a decision. It is still early days, but we look forward to seeing the outcome.'
